HCWB insider trading
NasdaqCM HealthcareHCW Biologics Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.
About HCW Biologics Inc.
HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and diseases in the United States. Its lead products include HCW11-018b, a novel, tetra-valent T-Cell engager; HCW11-040, a multifunctional fusion molecule that is a combination of cytokines and pembrolizumab; and HCW9302, injectable and interleukin 2 (IL-2) fusion protein complex, which is in phase 1 for alopecia areata diseases. The company also develops HCW9201, a fusion protein designed as a reagent to use in the production of natural killer (NK) cell-based therapies; HCW9206, a fusion protein designed as a reagent to use in the production of CAR-therapies for the treatment of infectious diseases; and HCW11-006, an immune cell stimulator. It has a license agreement with Wugen Inc. to develop cell therapy-based treatments; and a license, research and co-development agreement with WY Biotech Co., Ltd. for its preclinical molecules. HCW Biologics Inc. was incorporated in 2018 and is headquartered in Miramar, Florida.
Company website: www.hcwbiologics.com
HCWB insider activity at a glance
FilingIQ has scored 115 insider transactions for HCWB since Jul 22, 2021. The most recent filing in our index is dated May 22, 2026.
Across the full history, 91 open-market purchases
and 0 open-market sales
were filed under transaction codes P and S respectively. Compensatory share awards
(code A) and option exercises (code M) are tracked separately and not counted here.
The average FilingIQ composite score on HCWB insider trades is 62.6/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.
Latest HCWB Form 4 filings
Most recent disclosures. Sign up to filter by score, transaction code, or insider role.
Other Healthcare tickers with recent insider activity
Top insiders trading HCWB
Frequently asked
- How many insider trades does FilingIQ track for HCWB?
- FilingIQ tracks 115 Form 4 insider transactions for HCWB (HCW Biologics Inc.), covering filings from Jul 22, 2021 onwards. 6 of those were filed in the last 90 days.
- Are HCWB insiders net buyers or net sellers?
- Across the full Form 4 history for HCWB, 91 transactions (79%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
- Where does HCWB insider data come from?
- Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
- What sector is HCWB in?
- HCW Biologics Inc. (HCWB) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $15.68M.
Methodology & sources
Every HCWB insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.